Safety and Efficacy of Rodatristat Ethyl in the Treatment of Patients With Pulmonary Arterial Hypertension
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial
Lancet Respir Med 2024 Sep 19;[EPub Ahead of Print], O Sitbon, A Skride, J Feldman, S Sahay, OA Shlobin, V McLaughlin, HA Ghofrani, D Langleben, E Parsley, G D'Souza, T Marmon, W Kamau-Kelley, R Jones, R Grewal, S Wring, M Palacios, H Naik, J Denning, HM Lazarus, M HumbertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.